These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 11268357)

  • 1. Neural control of ocular immune privilege.
    Streilein JW; Okamoto S; Sano Y; Taylor AW
    Ann N Y Acad Sci; 2000; 917():297-306. PubMed ID: 11268357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the induction of anterior chamber-associated immune deviation (ACAID). III. Induction of ACAID depends upon intraocular transforming growth factor-beta.
    Wilbanks GA; Mammolenti M; Streilein JW
    Eur J Immunol; 1992 Jan; 22(1):165-73. PubMed ID: 1530916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunologic responses of the anterior chamber of the eye].
    Rocha G; Deschênes J; Baines MG
    Allergol Immunopathol (Madr); 1994; 22(1):23-7. PubMed ID: 8030580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the induction of anterior chamber-associated immune deviation (ACAID). 1. Evidence that an antigen-specific, ACAID-inducing, cell-associated signal exists in the peripheral blood.
    Wilbanks GA; Streilein JW
    J Immunol; 1991 Apr; 146(8):2610-7. PubMed ID: 1707912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aqueous humor factors and their effect on the immune response in the anterior chamber.
    Streilein JW; Cousins SW
    Curr Eye Res; 1990; 9 Suppl():175-82. PubMed ID: 2200643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anterior chamber associated immune deviation: the privilege of immunity in the eye.
    Streilein JW
    Surv Ophthalmol; 1990; 35(1):67-73. PubMed ID: 2204129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune privilege persists in eyes with extreme inflammation induced by intravitreal LPS.
    Mo JS; Streilein JW
    Eur J Immunol; 2001 Dec; 31(12):3806-15. PubMed ID: 11745402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Local production of IFN-gamma abrogates the intraocular immune privilege in transgenic mice and prevents the induction of ACAID.
    Geiger K; Sarvetnick N
    J Immunol; 1994 Dec; 153(11):5239-46. PubMed ID: 7525729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ocular immune privilege sites.
    Masli S; Vega JL
    Methods Mol Biol; 2011; 677():449-58. PubMed ID: 20941626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eye-derived cytokines and the immunosuppressive intraocular microenvironment: a review.
    Streilein JW; Wilbanks GA; Taylor A; Cousins S
    Curr Eye Res; 1992; 11 Suppl():41-7. PubMed ID: 1424750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune privilege in corneal transplantation.
    Hori J; Yamaguchi T; Keino H; Hamrah P; Maruyama K
    Prog Retin Eye Res; 2019 Sep; 72():100758. PubMed ID: 31014973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of splenic B cells in the immune privilege of the anterior chamber of the eye.
    Niederkorn JY; Mayhew E
    Eur J Immunol; 1995 Oct; 25(10):2783-7. PubMed ID: 7589072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological non-responsiveness and acquisition of tolerance in relation to immune privilege in the eye.
    Streilein JW
    Eye (Lond); 1995; 9 ( Pt 2)():236-40. PubMed ID: 7556724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ocular immune privilege promoted by the presentation of peptide on tolerogenic B cells in the spleen. II. Evidence for presentation by Qa-1.
    D'Orazio TJ; Mayhew E; Niederkorn JY
    J Immunol; 2001 Jan; 166(1):26-32. PubMed ID: 11123273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune Privilege and Eye-Derived T-Regulatory Cells.
    Keino H; Horie S; Sugita S
    J Immunol Res; 2018; 2018():1679197. PubMed ID: 29888291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The induction of anterior chamber-associated immune deviation.
    Niederkorn JY
    Chem Immunol Allergy; 2007; 92():27-35. PubMed ID: 17264480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-1 receptor antagonist suppresses Langerhans cell activity and promotes ocular immune privilege.
    Dana MR; Dai R; Zhu S; Yamada J; Streilein JW
    Invest Ophthalmol Vis Sci; 1998 Jan; 39(1):70-7. PubMed ID: 9430547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical denervation of ocular sympathetic afferents decreases local transforming growth factor-beta and abolishes immune privilege.
    Vega JL; Keino H; Masli S
    Am J Pathol; 2009 Sep; 175(3):1218-25. PubMed ID: 19700755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pigment Dispersion Contributes to Ocular Immune Privilege in a DBA/2J Mouse Model of Pigmentary Glaucoma.
    Li Q; Pu L; Cheng S; Tang S; Zhang J; Qing G
    Invest Ophthalmol Vis Sci; 2024 Jul; 65(8):51. PubMed ID: 39083309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of Contrasuppressor Cells and Loss of Immune Privilege Produced by Corneal Nerve Ablation.
    Neelam S; Mellon J; Wilkerson A; Niederkorn JY
    Invest Ophthalmol Vis Sci; 2018 Sep; 59(11):4738-4747. PubMed ID: 30267096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.